ReviewFrontiers in immunology2025
Development and landscape of maintenance therapy after first-line treatment of advanced or metastatic urothelial carcinoma.
Zengguang Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ReviewFrontiers in immunology2025
Zengguang Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.